Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Pharmaceuticals Newsletter 2004, No. 01
(2004; 17 pages) View the PDF document
Table of Contents
Open this folder and view contentsREGULATORY MATTERS
Open this folder and view contentsSAFETY OF MEDICINES
Open this folder and view contentsDRUGS OF CURRENT INTEREST
Open this folder and view contentsFEATURE
 

WHO Pharmaceuticals Newsletter 2004, No. 01

EDITORIAL

It was good seeing many of you in India during the Twenty-sixth Annual Meeting of the National Centres participating in the WHO International Drug Monitoring Programme. The working groups at the meeting debated on system differences and ways in which countries could learn from each other for improved reporting of adverse drug reactions. No doubt this last meeting will set the agenda for activities in pharmacovigilance for the current year. Implementing the suggestions into practice, in real terms, will be a challenge. Preparations are in full swing for the ICDRA meeting to be held in Spain 16-19 February 2004. A pre-ICDRA satellite workshop on counterfeit drugs will address important questions and problems pertaining to fake - drugs the world over. We are in the process of revising the National Information Officers List; we are happy to note that many of the Member States have already responded with updated information and we hope to hear from the others before the turn of the month. And last, but not least, we wish all our readers a very happy new year in 2004.

 

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: June 25, 2014